LENSAR, Inc.

NasdaqCM LNSR

LENSAR, Inc. Net Cash Used For Investing Activities for the Trailing 12 Months (TTM) ending September 30, 2024: USD -8.12 M

LENSAR, Inc. Net Cash Used For Investing Activities is USD -8.12 M for the Trailing 12 Months (TTM) ending September 30, 2024, a -3,173.39% change year over year. Net cash used for investing activities is total cash inflows and outflows related to activities intended to generate future income and cash flows from investments.
  • LENSAR, Inc. Net Cash Used For Investing Activities for the Trailing 12 Months (TTM) ending September 30, 2023 was USD -248.00 K, a -15.89% change year over year.
  • LENSAR, Inc. Net Cash Used For Investing Activities for the Trailing 12 Months (TTM) ending September 30, 2022 was USD -214.00 K, a 29.37% change year over year.
  • LENSAR, Inc. Net Cash Used For Investing Activities for the Trailing 12 Months (TTM) ending September 30, 2021 was USD -303.00 K, a -3.77% change year over year.
  • LENSAR, Inc. Net Cash Used For Investing Activities for the Trailing 12 Months (TTM) ending September 30, 2020 was USD -292.00 K.
Key data
Date Net Cash Used For Investing Activities Net Cash Used Provided By Financing Activities Dividends Paid Capital Expenditure
Market news
Loading...
SV Wall Street
NasdaqCM: LNSR

LENSAR, Inc.

CEO Mr. Nicholas T. Curtis
IPO Date Oct. 2, 2020
Location United States
Headquarters 2800 Discovery Drive
Employees 130
Sector Consumer Discretionary
Industries
Description

LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its LENSAR Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision. The company was incorporated in 2004 and is headquartered in Orlando, Florida.

Similar companies

IRIX

IRIDEX Corporation

USD 1.64

0.00%

OFIX

Orthofix Medical Inc.

USD 18.20

-0.71%

NPCE

NeuroPace, Inc.

USD 13.61

-1.09%

SGHT

Sight Sciences, Inc.

USD 2.73

-2.50%

SSKN

STRATA Skin Sciences, Inc.

USD 2.83

4.04%

AXGN

AxoGen, Inc.

USD 17.92

-1.59%

SRDX

Surmodics, Inc.

USD 34.07

0.09%

RXST

RxSight, Inc.

USD 33.70

-0.50%

TMCI

Treace Medical Concepts, Inc.

USD 9.69

-3.58%

LUNG

Pulmonx Corporation

USD 5.84

2.82%

StockViz Staff

February 4, 2025

Any question? Send us an email